Home Biosimilar Antibodies GPCR & G Protein cAMP Zelminemab (Anti-PAC1)
For research use only. Not for use in humans.

Zelminemab (Anti-PAC1)

Synonyms: AMG-301

Zelminemab (AMG-301) is a human monoclonal antibody that inhibits the PACAP type I (PAC1) receptor. MW: 145.5 kD.

Zelminemab (Anti-PAC1)

Quality Control

  • Cited in Nature Medicine for its top-tier quality
  • SDS
  • Datasheet

Specificity

Name Citation AC EPAC1 EPAC2 PACAP receptor cAMP Others
ESI-05 0
NE 52-QQ57 1 TNF-α,PGE2,COX2
ST034307 0
PACAP 6-38 acetate 1 CARTp
Bithionol 3
ESI-09 14
HJC0350 1
HJC0197 0
PACAP 1-27 0
SQ22536 29
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Mechanism of Action

Description
Zelminemab (AMG-301) is a human monoclonal antibody that inhibits the PACAP type I (PAC1) receptor. MW: 145.5 kD.

Product Details

CAS No. 2225850-33-7
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.